Injective brings Apple, Tesla, and more from the Magnificent 7 onchain via Helix, enabling 24/7 trading and redefining the future of DeFi
Author: Chirag Sharma
In a major breakthrough for decentralized finance (DeFi), the Magnificent 7 stocks—Apple ($AAPL), Microsoft ($MSFT), Amazon ($AMZN), Nvidia ($NVDA), Meta ($META), Google ($GOOGL), and Tesla ($TSLA)—are now fully tradable onchain via Injective iAsset framework. Announced on May 6, 2025, this move introduces 24/7 trading of some of the world’s most influential stocks on the Helix decentralized exchange, built on Injective’s layer-1 blockchain.
Unlike traditional tokenized assets, Injective’s iAssets offer permissionless, fully decentralized trading—eliminating the need for intermediaries and sidestepping traditional trading limitations like market hours. This advancement enhances transparency, global accessibility, and user autonomy, laying the groundwork for a borderless financial ecosystem.
Combined, the Magnificent 7 stocks represent over $15 trillion in market capitalization and are synonymous with tech innovation and economic power. By bringing these giants onchain, Injective isn’t just bridging TradFi and DeFi—it’s redefining market access itself.
The Helix platform allows users to trade these assets with low fees, full self-custody, and real-time settlement, no matter where they are. This marks a significant departure from centralized systems, offering a glimpse into the future of finance—one where barriers to entry are dismantled and markets operate continuously.
Industry voices are calling this move more than tokenization—it’s a complete shift in how financial systems function. “Injective is building the backbone of a decentralized Wall Street,” said one DeFi analyst. With hints of more iAssets and innovations on the horizon, Injective is positioning itself as a leader in the DeFi movement.
As global markets evolve, this integration of magnificent 7 by injective may inspire other protocols and institutions to follow suit. The onchain finance era is underway, and Injective is leading the charge into uncharted territory.
For individual investors, this opens unprecedented opportunities. You can now trade these iconic stocks without relying on traditional brokers, navigating restrictive hours, or facing high fees. Whether you’re a retail trader or a DeFi enthusiast, Injective’s platform provides direct access to these assets in a secure, decentralized environment. This levels the playing field, especially for those in underserved regions with limited access to global markets. Additionally, 24/7 allows you to react instantly to market movements, while blockchain transparency ensures trust in every transaction. As Injective continues to innovate, early adopters could gain a front-row seat to a financial revolution.
Industry analysts view this as a transformative step. “Injective is redefining how finance operates,” said a DeFi expert. With Injective hinting at further disruptions, the platform could reshape Wall Street itself. Traders are encouraged to explore Helix and prepare for a new era of finance. The onchain revolution is here, and Injective is leading the way.
Our Crypto Talk is committed to unbiased, transparent, and true reporting to the best of our knowledge. This news article aims to provide accurate information in a timely manner. However, we advise the readers to verify facts independently and consult a professional before making any decisions based on the content since our sources could be wrong too. Check our Terms and conditions for more info.
Ledger Probes User Fund Losses Tied to Reseller CryptoBilis
Why Provenance Blockchain (HASH) Is Up 39.6% Today?
Halborn Clears XMAQUINA RCM Audit With Zero Critical Bugs
Fidelity Scoops $354M Bitcoin, ETH & SOL in 20 Days
Ledger Probes User Fund Losses Tied to Reseller CryptoBilis
Why Provenance Blockchain (HASH) Is Up 39.6% Today?
Halborn Clears XMAQUINA RCM Audit With Zero Critical Bugs
Fidelity Scoops $354M Bitcoin, ETH & SOL in 20 Days
